Cholangiocarcinoma


Precision medicine bursts onto the biliary tract cancer scene

The management of biliary tract cancers, especially cholangiocarcinoma, is rapidly changing with emerging new precision medicine strategies. “Most research is focused on patients harbouring fibroblast growth factor receptor-2 (FGFR2) fusions and isocitrate dehydrogenase-1 (IDH1) mutations,…

Read More